Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-21-024772

Director acquired 314 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ASELAGE STEVE Director 2021-08-31 Grant or award +314 $15.92 $4,999 32,444 D
Loading xslF345X03/form4.xml…